nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—Irinotecan—colon cancer	0.13	0.195	CbGbCtD
Rabeprazole—ABCG2—Fluorouracil—colon cancer	0.125	0.187	CbGbCtD
Rabeprazole—ABCG2—Vincristine—colon cancer	0.114	0.171	CbGbCtD
Rabeprazole—CYP2C9—Capecitabine—colon cancer	0.0784	0.117	CbGbCtD
Rabeprazole—ABCG2—Methotrexate—colon cancer	0.069	0.103	CbGbCtD
Rabeprazole—CYP1A2—Fluorouracil—colon cancer	0.0516	0.0773	CbGbCtD
Rabeprazole—CYP2C9—Fluorouracil—colon cancer	0.0465	0.0696	CbGbCtD
Rabeprazole—CYP3A4—Irinotecan—colon cancer	0.0282	0.0422	CbGbCtD
Rabeprazole—CYP3A4—Vincristine—colon cancer	0.0246	0.0369	CbGbCtD
Rabeprazole—ATP4B—digestive system—colon cancer	0.00536	0.161	CbGeAlD
Rabeprazole—ATP4B—liver—colon cancer	0.00399	0.12	CbGeAlD
Rabeprazole—ATP4A—epithelium—colon cancer	0.00307	0.0921	CbGeAlD
Rabeprazole—ATP4A—renal system—colon cancer	0.00284	0.0854	CbGeAlD
Rabeprazole—ATP4A—digestive system—colon cancer	0.00233	0.07	CbGeAlD
Rabeprazole—ATP4A—liver—colon cancer	0.00174	0.0522	CbGeAlD
Rabeprazole—Pantoprazole—ABCB1—colon cancer	0.0016	0.39	CrCbGaD
Rabeprazole—Omeprazole—ABCB1—colon cancer	0.0013	0.318	CrCbGaD
Rabeprazole—Lansoprazole—ABCB1—colon cancer	0.00119	0.291	CrCbGaD
Rabeprazole—CYP1A1—epithelium—colon cancer	0.000863	0.0259	CbGeAlD
Rabeprazole—CYP2C19—digestive system—colon cancer	0.000815	0.0245	CbGeAlD
Rabeprazole—CYP1A2—renal system—colon cancer	0.000811	0.0244	CbGeAlD
Rabeprazole—CYP1A1—renal system—colon cancer	0.0008	0.024	CbGeAlD
Rabeprazole—CYP2C19—vagina—colon cancer	0.00072	0.0216	CbGeAlD
Rabeprazole—CYP1A2—digestive system—colon cancer	0.000666	0.02	CbGeAlD
Rabeprazole—CYP1A1—digestive system—colon cancer	0.000657	0.0197	CbGeAlD
Rabeprazole—ABCG2—bone marrow—colon cancer	0.000637	0.0191	CbGeAlD
Rabeprazole—CYP2C9—digestive system—colon cancer	0.000632	0.019	CbGeAlD
Rabeprazole—ABCG2—vagina—colon cancer	0.000611	0.0183	CbGeAlD
Rabeprazole—CYP2C19—liver—colon cancer	0.000607	0.0182	CbGeAlD
Rabeprazole—CYP3A4—renal system—colon cancer	0.000587	0.0176	CbGeAlD
Rabeprazole—CYP1A1—vagina—colon cancer	0.00058	0.0174	CbGeAlD
Rabeprazole—CYP2D6—renal system—colon cancer	0.000578	0.0174	CbGeAlD
Rabeprazole—ABCG2—liver—colon cancer	0.000515	0.0155	CbGeAlD
Rabeprazole—CYP1A2—liver—colon cancer	0.000496	0.0149	CbGeAlD
Rabeprazole—CYP1A1—liver—colon cancer	0.000489	0.0147	CbGeAlD
Rabeprazole—CYP3A4—digestive system—colon cancer	0.000482	0.0145	CbGeAlD
Rabeprazole—CYP2D6—digestive system—colon cancer	0.000474	0.0142	CbGeAlD
Rabeprazole—CYP2C9—liver—colon cancer	0.000471	0.0141	CbGeAlD
Rabeprazole—Loss of consciousness—Irinotecan—colon cancer	0.000411	0.00139	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Capecitabine—colon cancer	0.00041	0.00139	CcSEcCtD
Rabeprazole—Myalgia—Vincristine—colon cancer	0.000409	0.00139	CcSEcCtD
Rabeprazole—Weight increased—Capecitabine—colon cancer	0.000409	0.00139	CcSEcCtD
Rabeprazole—Cough—Irinotecan—colon cancer	0.000408	0.00138	CcSEcCtD
Rabeprazole—Weight decreased—Capecitabine—colon cancer	0.000407	0.00138	CcSEcCtD
Rabeprazole—Hyperglycaemia—Capecitabine—colon cancer	0.000405	0.00137	CcSEcCtD
Rabeprazole—Hypertension—Irinotecan—colon cancer	0.000404	0.00137	CcSEcCtD
Rabeprazole—Pneumonia—Capecitabine—colon cancer	0.000403	0.00137	CcSEcCtD
Rabeprazole—Leukopenia—Fluorouracil—colon cancer	0.000401	0.00136	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000397	0.00135	CcSEcCtD
Rabeprazole—ABCG2—lymph node—colon cancer	0.000395	0.0119	CbGeAlD
Rabeprazole—Acute coronary syndrome—Capecitabine—colon cancer	0.000395	0.00134	CcSEcCtD
Rabeprazole—Discomfort—Irinotecan—colon cancer	0.000394	0.00133	CcSEcCtD
Rabeprazole—Myocardial infarction—Capecitabine—colon cancer	0.000393	0.00133	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Capecitabine—colon cancer	0.000393	0.00133	CcSEcCtD
Rabeprazole—Anaphylactic shock—Vincristine—colon cancer	0.000392	0.00133	CcSEcCtD
Rabeprazole—Oedema—Vincristine—colon cancer	0.000392	0.00133	CcSEcCtD
Rabeprazole—Stomatitis—Capecitabine—colon cancer	0.000391	0.00132	CcSEcCtD
Rabeprazole—Jaundice—Capecitabine—colon cancer	0.000391	0.00132	CcSEcCtD
Rabeprazole—Conjunctivitis—Capecitabine—colon cancer	0.000389	0.00132	CcSEcCtD
Rabeprazole—Urinary tract infection—Capecitabine—colon cancer	0.000389	0.00132	CcSEcCtD
Rabeprazole—Convulsion—Fluorouracil—colon cancer	0.000388	0.00132	CcSEcCtD
Rabeprazole—Osteoarthritis—Methotrexate—colon cancer	0.000387	0.00131	CcSEcCtD
Rabeprazole—Confusional state—Irinotecan—colon cancer	0.000385	0.00131	CcSEcCtD
Rabeprazole—Thrombocytopenia—Vincristine—colon cancer	0.000384	0.0013	CcSEcCtD
Rabeprazole—Haematuria—Capecitabine—colon cancer	0.000382	0.0013	CcSEcCtD
Rabeprazole—Anaphylactic shock—Irinotecan—colon cancer	0.000382	0.00129	CcSEcCtD
Rabeprazole—Oedema—Irinotecan—colon cancer	0.000382	0.00129	CcSEcCtD
Rabeprazole—Myalgia—Fluorouracil—colon cancer	0.000381	0.00129	CcSEcCtD
Rabeprazole—Chest pain—Fluorouracil—colon cancer	0.000381	0.00129	CcSEcCtD
Rabeprazole—Hyperhidrosis—Vincristine—colon cancer	0.000379	0.00128	CcSEcCtD
Rabeprazole—Epistaxis—Capecitabine—colon cancer	0.000378	0.00128	CcSEcCtD
Rabeprazole—Discomfort—Fluorouracil—colon cancer	0.000377	0.00128	CcSEcCtD
Rabeprazole—Shock—Irinotecan—colon cancer	0.000376	0.00127	CcSEcCtD
Rabeprazole—CYP1A1—lymph node—colon cancer	0.000375	0.0113	CbGeAlD
Rabeprazole—Agranulocytosis—Capecitabine—colon cancer	0.000374	0.00127	CcSEcCtD
Rabeprazole—Thrombocytopenia—Irinotecan—colon cancer	0.000374	0.00127	CcSEcCtD
Rabeprazole—Anorexia—Vincristine—colon cancer	0.000374	0.00127	CcSEcCtD
Rabeprazole—Hyperhidrosis—Irinotecan—colon cancer	0.000369	0.00125	CcSEcCtD
Rabeprazole—Confusional state—Fluorouracil—colon cancer	0.000369	0.00125	CcSEcCtD
Rabeprazole—Hypotension—Vincristine—colon cancer	0.000366	0.00124	CcSEcCtD
Rabeprazole—Bradycardia—Capecitabine—colon cancer	0.000366	0.00124	CcSEcCtD
Rabeprazole—Anaphylactic shock—Fluorouracil—colon cancer	0.000366	0.00124	CcSEcCtD
Rabeprazole—Oedema—Fluorouracil—colon cancer	0.000366	0.00124	CcSEcCtD
Rabeprazole—Anorexia—Irinotecan—colon cancer	0.000364	0.00123	CcSEcCtD
Rabeprazole—Rhinitis—Capecitabine—colon cancer	0.000361	0.00122	CcSEcCtD
Rabeprazole—Hepatitis—Capecitabine—colon cancer	0.00036	0.00122	CcSEcCtD
Rabeprazole—CYP3A4—liver—colon cancer	0.000359	0.0108	CbGeAlD
Rabeprazole—Thrombocytopenia—Fluorouracil—colon cancer	0.000358	0.00121	CcSEcCtD
Rabeprazole—Liver function test abnormal—Methotrexate—colon cancer	0.000357	0.00121	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000357	0.00121	CcSEcCtD
Rabeprazole—Pharyngitis—Capecitabine—colon cancer	0.000357	0.00121	CcSEcCtD
Rabeprazole—Tachycardia—Fluorouracil—colon cancer	0.000357	0.00121	CcSEcCtD
Rabeprazole—Hypotension—Irinotecan—colon cancer	0.000357	0.00121	CcSEcCtD
Rabeprazole—Urinary tract disorder—Capecitabine—colon cancer	0.000355	0.0012	CcSEcCtD
Rabeprazole—Insomnia—Vincristine—colon cancer	0.000355	0.0012	CcSEcCtD
Rabeprazole—Oedema peripheral—Capecitabine—colon cancer	0.000354	0.0012	CcSEcCtD
Rabeprazole—CYP2D6—liver—colon cancer	0.000353	0.0106	CbGeAlD
Rabeprazole—Urethral disorder—Capecitabine—colon cancer	0.000353	0.0012	CcSEcCtD
Rabeprazole—Paraesthesia—Vincristine—colon cancer	0.000352	0.00119	CcSEcCtD
Rabeprazole—Anorexia—Fluorouracil—colon cancer	0.000349	0.00118	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000349	0.00118	CcSEcCtD
Rabeprazole—Visual impairment—Capecitabine—colon cancer	0.000347	0.00118	CcSEcCtD
Rabeprazole—Insomnia—Irinotecan—colon cancer	0.000345	0.00117	CcSEcCtD
Rabeprazole—Paraesthesia—Irinotecan—colon cancer	0.000343	0.00116	CcSEcCtD
Rabeprazole—Hypotension—Fluorouracil—colon cancer	0.000342	0.00116	CcSEcCtD
Rabeprazole—Decreased appetite—Vincristine—colon cancer	0.000341	0.00116	CcSEcCtD
Rabeprazole—Dyspnoea—Irinotecan—colon cancer	0.00034	0.00115	CcSEcCtD
Rabeprazole—Erythema multiforme—Capecitabine—colon cancer	0.00034	0.00115	CcSEcCtD
Rabeprazole—Somnolence—Irinotecan—colon cancer	0.000339	0.00115	CcSEcCtD
Rabeprazole—Eye disorder—Capecitabine—colon cancer	0.000336	0.00114	CcSEcCtD
Rabeprazole—Dyspepsia—Irinotecan—colon cancer	0.000336	0.00114	CcSEcCtD
Rabeprazole—Tinnitus—Capecitabine—colon cancer	0.000335	0.00114	CcSEcCtD
Rabeprazole—Pain—Vincristine—colon cancer	0.000335	0.00114	CcSEcCtD
Rabeprazole—Constipation—Vincristine—colon cancer	0.000335	0.00114	CcSEcCtD
Rabeprazole—Asthma—Methotrexate—colon cancer	0.000335	0.00113	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000333	0.00113	CcSEcCtD
Rabeprazole—Decreased appetite—Irinotecan—colon cancer	0.000332	0.00113	CcSEcCtD
Rabeprazole—Insomnia—Fluorouracil—colon cancer	0.000331	0.00112	CcSEcCtD
Rabeprazole—Paraesthesia—Fluorouracil—colon cancer	0.000328	0.00111	CcSEcCtD
Rabeprazole—Pancreatitis—Methotrexate—colon cancer	0.000328	0.00111	CcSEcCtD
Rabeprazole—Pain—Irinotecan—colon cancer	0.000327	0.00111	CcSEcCtD
Rabeprazole—Constipation—Irinotecan—colon cancer	0.000327	0.00111	CcSEcCtD
Rabeprazole—Angiopathy—Capecitabine—colon cancer	0.000326	0.00111	CcSEcCtD
Rabeprazole—Dyspnoea—Fluorouracil—colon cancer	0.000326	0.00111	CcSEcCtD
Rabeprazole—Somnolence—Fluorouracil—colon cancer	0.000325	0.0011	CcSEcCtD
Rabeprazole—Chills—Capecitabine—colon cancer	0.000323	0.00109	CcSEcCtD
Rabeprazole—Dyspepsia—Fluorouracil—colon cancer	0.000322	0.00109	CcSEcCtD
Rabeprazole—Arrhythmia—Capecitabine—colon cancer	0.000321	0.00109	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Vincristine—colon cancer	0.000321	0.00109	CcSEcCtD
Rabeprazole—Decreased appetite—Fluorouracil—colon cancer	0.000318	0.00108	CcSEcCtD
Rabeprazole—Alopecia—Capecitabine—colon cancer	0.000318	0.00108	CcSEcCtD
Rabeprazole—Pancytopenia—Methotrexate—colon cancer	0.000318	0.00108	CcSEcCtD
Rabeprazole—Feeling abnormal—Irinotecan—colon cancer	0.000315	0.00107	CcSEcCtD
Rabeprazole—Malnutrition—Capecitabine—colon cancer	0.000313	0.00106	CcSEcCtD
Rabeprazole—Erythema—Capecitabine—colon cancer	0.000313	0.00106	CcSEcCtD
Rabeprazole—Neutropenia—Methotrexate—colon cancer	0.000313	0.00106	CcSEcCtD
Rabeprazole—Dysuria—Methotrexate—colon cancer	0.000313	0.00106	CcSEcCtD
Rabeprazole—Pain—Fluorouracil—colon cancer	0.000313	0.00106	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Irinotecan—colon cancer	0.000312	0.00106	CcSEcCtD
Rabeprazole—Body temperature increased—Vincristine—colon cancer	0.00031	0.00105	CcSEcCtD
Rabeprazole—Abdominal pain—Vincristine—colon cancer	0.00031	0.00105	CcSEcCtD
Rabeprazole—Flatulence—Capecitabine—colon cancer	0.000309	0.00105	CcSEcCtD
Rabeprazole—Erectile dysfunction—Methotrexate—colon cancer	0.000308	0.00104	CcSEcCtD
Rabeprazole—Dysgeusia—Capecitabine—colon cancer	0.000307	0.00104	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Methotrexate—colon cancer	0.000305	0.00104	CcSEcCtD
Rabeprazole—Back pain—Capecitabine—colon cancer	0.000303	0.00103	CcSEcCtD
Rabeprazole—Abdominal pain—Irinotecan—colon cancer	0.000302	0.00102	CcSEcCtD
Rabeprazole—Body temperature increased—Irinotecan—colon cancer	0.000302	0.00102	CcSEcCtD
Rabeprazole—Feeling abnormal—Fluorouracil—colon cancer	0.000301	0.00102	CcSEcCtD
Rabeprazole—Muscle spasms—Capecitabine—colon cancer	0.000301	0.00102	CcSEcCtD
Rabeprazole—Pneumonia—Methotrexate—colon cancer	0.0003	0.00102	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000296	0.001	CcSEcCtD
Rabeprazole—Vision blurred—Capecitabine—colon cancer	0.000295	0.001	CcSEcCtD
Rabeprazole—Tremor—Capecitabine—colon cancer	0.000293	0.000994	CcSEcCtD
Rabeprazole—Stomatitis—Methotrexate—colon cancer	0.000291	0.000986	CcSEcCtD
Rabeprazole—Ill-defined disorder—Capecitabine—colon cancer	0.000291	0.000985	CcSEcCtD
Rabeprazole—Urticaria—Fluorouracil—colon cancer	0.000291	0.000985	CcSEcCtD
Rabeprazole—Conjunctivitis—Methotrexate—colon cancer	0.00029	0.000983	CcSEcCtD
Rabeprazole—Anaemia—Capecitabine—colon cancer	0.000289	0.000981	CcSEcCtD
Rabeprazole—Body temperature increased—Fluorouracil—colon cancer	0.000289	0.00098	CcSEcCtD
Rabeprazole—Hypersensitivity—Vincristine—colon cancer	0.000289	0.000979	CcSEcCtD
Rabeprazole—Sweating—Methotrexate—colon cancer	0.000286	0.000969	CcSEcCtD
Rabeprazole—Haematuria—Methotrexate—colon cancer	0.000284	0.000964	CcSEcCtD
Rabeprazole—Malaise—Capecitabine—colon cancer	0.000282	0.000957	CcSEcCtD
Rabeprazole—Epistaxis—Methotrexate—colon cancer	0.000281	0.000954	CcSEcCtD
Rabeprazole—Vertigo—Capecitabine—colon cancer	0.000281	0.000954	CcSEcCtD
Rabeprazole—Hypersensitivity—Irinotecan—colon cancer	0.000281	0.000954	CcSEcCtD
Rabeprazole—Asthenia—Vincristine—colon cancer	0.000281	0.000954	CcSEcCtD
Rabeprazole—Syncope—Capecitabine—colon cancer	0.000281	0.000952	CcSEcCtD
Rabeprazole—Leukopenia—Capecitabine—colon cancer	0.00028	0.00095	CcSEcCtD
Rabeprazole—Agranulocytosis—Methotrexate—colon cancer	0.000278	0.000944	CcSEcCtD
Rabeprazole—Palpitations—Capecitabine—colon cancer	0.000277	0.000938	CcSEcCtD
Rabeprazole—Loss of consciousness—Capecitabine—colon cancer	0.000275	0.000933	CcSEcCtD
Rabeprazole—Asthenia—Irinotecan—colon cancer	0.000274	0.000929	CcSEcCtD
Rabeprazole—Cough—Capecitabine—colon cancer	0.000273	0.000926	CcSEcCtD
Rabeprazole—Hypertension—Capecitabine—colon cancer	0.00027	0.000916	CcSEcCtD
Rabeprazole—Hypersensitivity—Fluorouracil—colon cancer	0.000269	0.000913	CcSEcCtD
Rabeprazole—Diarrhoea—Vincristine—colon cancer	0.000268	0.000909	CcSEcCtD
Rabeprazole—Hepatitis—Methotrexate—colon cancer	0.000268	0.000908	CcSEcCtD
Rabeprazole—Chest pain—Capecitabine—colon cancer	0.000267	0.000904	CcSEcCtD
Rabeprazole—Myalgia—Capecitabine—colon cancer	0.000267	0.000904	CcSEcCtD
Rabeprazole—Arthralgia—Capecitabine—colon cancer	0.000267	0.000904	CcSEcCtD
Rabeprazole—Pharyngitis—Methotrexate—colon cancer	0.000266	0.000901	CcSEcCtD
Rabeprazole—Anxiety—Capecitabine—colon cancer	0.000266	0.000901	CcSEcCtD
Rabeprazole—Urinary tract disorder—Methotrexate—colon cancer	0.000264	0.000896	CcSEcCtD
Rabeprazole—Discomfort—Capecitabine—colon cancer	0.000263	0.000893	CcSEcCtD
Rabeprazole—Urethral disorder—Methotrexate—colon cancer	0.000262	0.00089	CcSEcCtD
Rabeprazole—Diarrhoea—Irinotecan—colon cancer	0.000261	0.000886	CcSEcCtD
Rabeprazole—Dry mouth—Capecitabine—colon cancer	0.000261	0.000884	CcSEcCtD
Rabeprazole—Dizziness—Vincristine—colon cancer	0.000259	0.000879	CcSEcCtD
Rabeprazole—Pruritus—Fluorouracil—colon cancer	0.000259	0.000877	CcSEcCtD
Rabeprazole—Visual impairment—Methotrexate—colon cancer	0.000258	0.000875	CcSEcCtD
Rabeprazole—Confusional state—Capecitabine—colon cancer	0.000258	0.000873	CcSEcCtD
Rabeprazole—Oedema—Capecitabine—colon cancer	0.000256	0.000866	CcSEcCtD
Rabeprazole—Erythema multiforme—Methotrexate—colon cancer	0.000253	0.000858	CcSEcCtD
Rabeprazole—Dizziness—Irinotecan—colon cancer	0.000252	0.000856	CcSEcCtD
Rabeprazole—Shock—Capecitabine—colon cancer	0.000251	0.000852	CcSEcCtD
Rabeprazole—Eye disorder—Methotrexate—colon cancer	0.00025	0.000848	CcSEcCtD
Rabeprazole—Diarrhoea—Fluorouracil—colon cancer	0.00025	0.000848	CcSEcCtD
Rabeprazole—Thrombocytopenia—Capecitabine—colon cancer	0.00025	0.000848	CcSEcCtD
Rabeprazole—Tinnitus—Methotrexate—colon cancer	0.00025	0.000846	CcSEcCtD
Rabeprazole—Tachycardia—Capecitabine—colon cancer	0.000249	0.000845	CcSEcCtD
Rabeprazole—Vomiting—Vincristine—colon cancer	0.000249	0.000845	CcSEcCtD
Rabeprazole—Rash—Vincristine—colon cancer	0.000247	0.000838	CcSEcCtD
Rabeprazole—Hyperhidrosis—Capecitabine—colon cancer	0.000247	0.000837	CcSEcCtD
Rabeprazole—Dermatitis—Vincristine—colon cancer	0.000247	0.000837	CcSEcCtD
Rabeprazole—Headache—Vincristine—colon cancer	0.000246	0.000833	CcSEcCtD
Rabeprazole—Anorexia—Capecitabine—colon cancer	0.000244	0.000826	CcSEcCtD
Rabeprazole—Angiopathy—Methotrexate—colon cancer	0.000243	0.000824	CcSEcCtD
Rabeprazole—Vomiting—Irinotecan—colon cancer	0.000243	0.000823	CcSEcCtD
Rabeprazole—Dizziness—Fluorouracil—colon cancer	0.000242	0.00082	CcSEcCtD
Rabeprazole—Rash—Irinotecan—colon cancer	0.000241	0.000816	CcSEcCtD
Rabeprazole—Dermatitis—Irinotecan—colon cancer	0.000241	0.000815	CcSEcCtD
Rabeprazole—Chills—Methotrexate—colon cancer	0.00024	0.000814	CcSEcCtD
Rabeprazole—Headache—Irinotecan—colon cancer	0.000239	0.000811	CcSEcCtD
Rabeprazole—Hypotension—Capecitabine—colon cancer	0.000239	0.000809	CcSEcCtD
Rabeprazole—Alopecia—Methotrexate—colon cancer	0.000237	0.000802	CcSEcCtD
Rabeprazole—Erythema—Methotrexate—colon cancer	0.000233	0.00079	CcSEcCtD
Rabeprazole—Malnutrition—Methotrexate—colon cancer	0.000233	0.00079	CcSEcCtD
Rabeprazole—Nausea—Vincristine—colon cancer	0.000233	0.000789	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000233	0.000789	CcSEcCtD
Rabeprazole—Vomiting—Fluorouracil—colon cancer	0.000233	0.000788	CcSEcCtD
Rabeprazole—Insomnia—Capecitabine—colon cancer	0.000231	0.000784	CcSEcCtD
Rabeprazole—Rash—Fluorouracil—colon cancer	0.000231	0.000782	CcSEcCtD
Rabeprazole—Dermatitis—Fluorouracil—colon cancer	0.00023	0.000781	CcSEcCtD
Rabeprazole—Paraesthesia—Capecitabine—colon cancer	0.000229	0.000778	CcSEcCtD
Rabeprazole—Headache—Fluorouracil—colon cancer	0.000229	0.000777	CcSEcCtD
Rabeprazole—Dysgeusia—Methotrexate—colon cancer	0.000228	0.000774	CcSEcCtD
Rabeprazole—Dyspnoea—Capecitabine—colon cancer	0.000228	0.000772	CcSEcCtD
Rabeprazole—Nausea—Irinotecan—colon cancer	0.000227	0.000769	CcSEcCtD
Rabeprazole—Back pain—Methotrexate—colon cancer	0.000225	0.000764	CcSEcCtD
Rabeprazole—Dyspepsia—Capecitabine—colon cancer	0.000225	0.000763	CcSEcCtD
Rabeprazole—Decreased appetite—Capecitabine—colon cancer	0.000222	0.000753	CcSEcCtD
Rabeprazole—Vision blurred—Methotrexate—colon cancer	0.00022	0.000745	CcSEcCtD
Rabeprazole—Pain—Capecitabine—colon cancer	0.000219	0.000741	CcSEcCtD
Rabeprazole—Constipation—Capecitabine—colon cancer	0.000219	0.000741	CcSEcCtD
Rabeprazole—Nausea—Fluorouracil—colon cancer	0.000217	0.000736	CcSEcCtD
Rabeprazole—Ill-defined disorder—Methotrexate—colon cancer	0.000216	0.000733	CcSEcCtD
Rabeprazole—Anaemia—Methotrexate—colon cancer	0.000215	0.00073	CcSEcCtD
Rabeprazole—Feeling abnormal—Capecitabine—colon cancer	0.000211	0.000714	CcSEcCtD
Rabeprazole—Malaise—Methotrexate—colon cancer	0.00021	0.000713	CcSEcCtD
Rabeprazole—Vertigo—Methotrexate—colon cancer	0.000209	0.00071	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Capecitabine—colon cancer	0.000209	0.000708	CcSEcCtD
Rabeprazole—Leukopenia—Methotrexate—colon cancer	0.000209	0.000707	CcSEcCtD
Rabeprazole—Cough—Methotrexate—colon cancer	0.000203	0.00069	CcSEcCtD
Rabeprazole—Urticaria—Capecitabine—colon cancer	0.000203	0.000688	CcSEcCtD
Rabeprazole—Abdominal pain—Capecitabine—colon cancer	0.000202	0.000685	CcSEcCtD
Rabeprazole—Body temperature increased—Capecitabine—colon cancer	0.000202	0.000685	CcSEcCtD
Rabeprazole—Convulsion—Methotrexate—colon cancer	0.000202	0.000685	CcSEcCtD
Rabeprazole—Chest pain—Methotrexate—colon cancer	0.000198	0.000673	CcSEcCtD
Rabeprazole—Myalgia—Methotrexate—colon cancer	0.000198	0.000673	CcSEcCtD
Rabeprazole—Arthralgia—Methotrexate—colon cancer	0.000198	0.000673	CcSEcCtD
Rabeprazole—Discomfort—Methotrexate—colon cancer	0.000196	0.000665	CcSEcCtD
Rabeprazole—Confusional state—Methotrexate—colon cancer	0.000192	0.00065	CcSEcCtD
Rabeprazole—Anaphylactic shock—Methotrexate—colon cancer	0.00019	0.000645	CcSEcCtD
Rabeprazole—Hypersensitivity—Capecitabine—colon cancer	0.000188	0.000638	CcSEcCtD
Rabeprazole—Thrombocytopenia—Methotrexate—colon cancer	0.000186	0.000631	CcSEcCtD
Rabeprazole—Hyperhidrosis—Methotrexate—colon cancer	0.000184	0.000623	CcSEcCtD
Rabeprazole—Asthenia—Capecitabine—colon cancer	0.000183	0.000622	CcSEcCtD
Rabeprazole—Anorexia—Methotrexate—colon cancer	0.000181	0.000615	CcSEcCtD
Rabeprazole—Pruritus—Capecitabine—colon cancer	0.000181	0.000613	CcSEcCtD
Rabeprazole—Hypotension—Methotrexate—colon cancer	0.000178	0.000603	CcSEcCtD
Rabeprazole—Diarrhoea—Capecitabine—colon cancer	0.000175	0.000593	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000173	0.000588	CcSEcCtD
Rabeprazole—Insomnia—Methotrexate—colon cancer	0.000172	0.000583	CcSEcCtD
Rabeprazole—Paraesthesia—Methotrexate—colon cancer	0.000171	0.000579	CcSEcCtD
Rabeprazole—Dyspnoea—Methotrexate—colon cancer	0.00017	0.000575	CcSEcCtD
Rabeprazole—Somnolence—Methotrexate—colon cancer	0.000169	0.000573	CcSEcCtD
Rabeprazole—Dizziness—Capecitabine—colon cancer	0.000169	0.000573	CcSEcCtD
Rabeprazole—Dyspepsia—Methotrexate—colon cancer	0.000167	0.000568	CcSEcCtD
Rabeprazole—Decreased appetite—Methotrexate—colon cancer	0.000165	0.000561	CcSEcCtD
Rabeprazole—Pain—Methotrexate—colon cancer	0.000163	0.000551	CcSEcCtD
Rabeprazole—Vomiting—Capecitabine—colon cancer	0.000162	0.000551	CcSEcCtD
Rabeprazole—Rash—Capecitabine—colon cancer	0.000161	0.000546	CcSEcCtD
Rabeprazole—Dermatitis—Capecitabine—colon cancer	0.000161	0.000546	CcSEcCtD
Rabeprazole—Headache—Capecitabine—colon cancer	0.00016	0.000543	CcSEcCtD
Rabeprazole—Feeling abnormal—Methotrexate—colon cancer	0.000157	0.000531	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Methotrexate—colon cancer	0.000156	0.000527	CcSEcCtD
Rabeprazole—Nausea—Capecitabine—colon cancer	0.000152	0.000515	CcSEcCtD
Rabeprazole—Urticaria—Methotrexate—colon cancer	0.000151	0.000512	CcSEcCtD
Rabeprazole—Body temperature increased—Methotrexate—colon cancer	0.00015	0.00051	CcSEcCtD
Rabeprazole—Abdominal pain—Methotrexate—colon cancer	0.00015	0.00051	CcSEcCtD
Rabeprazole—Hypersensitivity—Methotrexate—colon cancer	0.00014	0.000475	CcSEcCtD
Rabeprazole—Asthenia—Methotrexate—colon cancer	0.000136	0.000463	CcSEcCtD
Rabeprazole—Pruritus—Methotrexate—colon cancer	0.000135	0.000456	CcSEcCtD
Rabeprazole—Diarrhoea—Methotrexate—colon cancer	0.00013	0.000441	CcSEcCtD
Rabeprazole—Dizziness—Methotrexate—colon cancer	0.000126	0.000426	CcSEcCtD
Rabeprazole—Vomiting—Methotrexate—colon cancer	0.000121	0.00041	CcSEcCtD
Rabeprazole—Rash—Methotrexate—colon cancer	0.00012	0.000407	CcSEcCtD
Rabeprazole—Dermatitis—Methotrexate—colon cancer	0.00012	0.000406	CcSEcCtD
Rabeprazole—Headache—Methotrexate—colon cancer	0.000119	0.000404	CcSEcCtD
Rabeprazole—Nausea—Methotrexate—colon cancer	0.000113	0.000383	CcSEcCtD
